South Africa and India have proposed a big change to the global rules that govern how drug discoveries are controlled and shared. They want a waiver on all patents and intellectual property rights worldwide for COVID-19 drugs and equipment for the duration of the pandemic. But as The World’s Elana Gordon reports, there are other options.